These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16758643)

  • 21. [Cancer of the breast in young women: should chemotherapy be intensified?].
    Piccart MJ
    Pathol Biol (Paris); 1992 Nov; 39(9):843-4. PubMed ID: 1371604
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer surgery.
    Ottosson S; Magnusson K; Hultborn R
    Anticancer Res; 1999; 19(5C):4429-34. PubMed ID: 10650787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What were the received dose intensities in the three arms?
    Hryniuk WM
    J Clin Oncol; 1991 Jul; 9(7):1321-2. PubMed ID: 2045873
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
    Elias AD; Ayash L; Tepler I; Wheeler C; Schwartz G; Mazanet R; Schnipper L; Frei E; Antman K
    J Hematother; 1993; 2(3):377-82. PubMed ID: 7522891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of angiogenesis and disease outcome in node-positive breast cancer patients treated with adjuvant cyclophosphamide, doxorubicin, and fluorouracil: a Cancer and Leukemia Group B correlative science study from protocols 8541/8869.
    Guidi AJ; Berry DA; Broadwater G; Helmchen B; Bleiweiss IJ; Budman DR; Henderson IC; Norton L; Hayes DF
    J Clin Oncol; 2002 Feb; 20(3):732-42. PubMed ID: 11821455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cell-cell interactions in the regulation of hemopoiesis during cytostatic-induced myelosuppression.
    Zhdanov VV; Udut EV; Gur'yantseva LA; Danilets MG; Dygai AM; Gol'dberg ED
    Bull Exp Biol Med; 2001 Aug; 132(2):744-7. PubMed ID: 11713554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
    Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy induced refractory anaemia with ring sideroblasts in carcinoma breast.
    Dhot PS; Sharma MC; Kumar L; Saxena R
    J Assoc Physicians India; 1994 Feb; 42(2):153-4. PubMed ID: 7860480
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of alternating combination chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, cisplatin, and etoposide for small cell lung cancer on hematopoietic progenitors in the peripheral blood.
    Shimizu E; Yamamoto A; Takahashi Y; Maniwa K; Yoshida S; Mukai J; Takaue Y; Ogura T
    Br J Cancer; 1993 Apr; 67(4):798-800. PubMed ID: 8385979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of pluripotent hemopoietic stem cells and clonable precursor cells of erythrocytes, granulocytes, macrophages and megakaryocytes from mouse bone marrow.
    Williams N; Jackson H; Meyers P
    Exp Hematol; 1979 Nov; 7(10):524-34. PubMed ID: 317649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of stimulation of granulocytopoiesis with neupogen in patients with breast cancer during chemotherapy.
    Khrichkova TY; Gol'dberg VE; Zhdanov VV; Matyash MG; Vysotckaya VV; Simolina EI; Shatalova VA; Popova NO; Miroshnichenko LA; Dygai AM
    Bull Exp Biol Med; 2008 Apr; 145(4):467-71. PubMed ID: 19110596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell kinetics of CD34-positive hematopoietic cells following chemotherapy plus colony-stimulating factors in advanced breast cancer.
    Danova M; Rosti V; Mazzini G; De Renzis MR; Locatelli F; Cazzola M; Riccardi A; Ascari E
    Int J Cancer; 1995 Nov; 63(5):646-51. PubMed ID: 7591280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant chemotherapy in breast cancer: back to the future.
    Colleoni M; Goldhirsch A
    Onkologie; 2003 Apr; 26(2):111-2. PubMed ID: 12771517
    [No Abstract]   [Full Text] [Related]  

  • 34. Mobilization of peripheral blood progenitor cells after induction chemotherapy (THP-doxorubicin-vinorelbine-cyclophosphamide-fluorouracil) and granulocyte colony-stimulating factor in breast cancer.
    Charrier S; Chassagne J; Curé H; Bay JO; Communal Y; Portefaix G; Ferrière JP; Bétail G; Plagne R; Chollet P
    Bone Marrow Transplant; 1998 Nov; 22(9):845-51. PubMed ID: 9827811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
    Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
    Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early suppressive effects of chemotherapy and cytokine treatment on committed versus primitive haemopoietic progenitors in patient bone marrow.
    Schwartz GN; Hakim F; Zujewski J; Szabo JM; Cepada R; Riseberg D; Warren MK; Mackall CL; Setzer A; Noone M; Cowan KH; O'Shaughnessy J; Gress RE
    Br J Haematol; 1996 Mar; 92(3):537-47. PubMed ID: 8616014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug therapy of pulmonary metastases of breast cancer].
    Voznyĭ EK; Meshcheriakova NG; Melent'eva EG; Al'tshuler IuB
    Sov Med; 1990; (5):110-4. PubMed ID: 2389192
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma.
    Zhang F; Yang Y; Smith T; Kau SW; McConathy JM; Esteva FJ; Kuerer HM; Symmans WF; Buzdar AU; Hortobagyi GN; Pusztai L
    Cancer; 2003 Apr; 97(7):1758-65. PubMed ID: 12655533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemotherapic management of genitomammary tumors].
    Sarría JA; Irigoyen ML; Cismondi B
    Rev Fac Cien Med Univ Nac Cordoba; 1981; 39(1-4):3-16. PubMed ID: 6897122
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adriablastin (doxorubicin) in the combined chemotherapy of patients with disseminated forms of breast cancer].
    Voznyĭ EK; Besova NS; Kurkina TV; Al'tshtuller IuB
    Antibiotiki; 1984 Jun; 29(6):463-8. PubMed ID: 6476811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.